BE872886A - Steroides, leur preparation et leur utilisation therapeutique - Google Patents

Steroides, leur preparation et leur utilisation therapeutique

Info

Publication number
BE872886A
BE872886A BE1009202A BE1009202A BE872886A BE 872886 A BE872886 A BE 872886A BE 1009202 A BE1009202 A BE 1009202A BE 1009202 A BE1009202 A BE 1009202A BE 872886 A BE872886 A BE 872886A
Authority
BE
Belgium
Prior art keywords
steroids
preparation
therapeutic use
therapeutic
Prior art date
Application number
BE1009202A
Other languages
English (en)
Inventor
R G Christiansen
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of BE872886A publication Critical patent/BE872886A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)
BE1009202A 1977-12-20 1978-12-20 Steroides, leur preparation et leur utilisation therapeutique BE872886A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,417 US4160027A (en) 1977-12-20 1977-12-20 Steroid cyanoketones and intermediates

Publications (1)

Publication Number Publication Date
BE872886A true BE872886A (fr) 1979-06-20

Family

ID=25338450

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1009202A BE872886A (fr) 1977-12-20 1978-12-20 Steroides, leur preparation et leur utilisation therapeutique

Country Status (27)

Country Link
US (1) US4160027A (fr)
JP (2) JPS5488253A (fr)
AR (1) AR222645A1 (fr)
AT (1) AT367070B (fr)
AU (1) AU518997B2 (fr)
BE (1) BE872886A (fr)
CA (1) CA1121340A (fr)
CH (1) CH637409A5 (fr)
DE (1) DE2855091A1 (fr)
DK (1) DK156727C (fr)
ES (1) ES476117A1 (fr)
FI (1) FI66010C (fr)
FR (1) FR2412569A1 (fr)
GB (2) GB2088878B (fr)
HK (1) HK89287A (fr)
IE (1) IE48076B1 (fr)
IL (1) IL56076A (fr)
IT (1) IT1195258B (fr)
LU (1) LU80673A1 (fr)
MX (1) MX5535E (fr)
NL (1) NL190848C (fr)
NO (1) NO151467C (fr)
NZ (1) NZ189035A (fr)
PH (2) PH14778A (fr)
PT (1) PT68926A (fr)
SE (1) SE433221B (fr)
ZA (1) ZA786746B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
ES526874A0 (es) * 1982-11-02 1985-05-01 Sterwin Ag Procedimiento de trituracion de compuestos esteroides
DK23984A (da) * 1983-02-11 1984-08-12 Hoffmann La Roche D-homosteroider
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
GB8404980D0 (en) * 1984-02-25 1984-03-28 Sterwin Ag Steroid compound
DE3531903A1 (de) * 1985-09-05 1987-03-12 Schering Ag Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US5795881A (en) * 1987-06-16 1998-08-18 Schering Aktiengesellschaft Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
US5215978A (en) * 1989-06-16 1993-06-01 The Upjohn Company Method of enhancing egg laying in turkeys using epostane
JPH0538929A (ja) * 1991-08-02 1993-02-19 Mitsubishi Heavy Ind Ltd 車両用空気調和装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
CN103169714A (zh) * 2005-07-12 2013-06-26 Dmi生物科学公司 治疗疾病的方法和产品
BRPI1010086A2 (pt) * 2009-06-22 2018-02-06 Dmi Acquisition Corp método e produtos para tratamento de doenças
KR101877041B1 (ko) * 2009-06-22 2018-07-10 앰피오 파마슈티컬스 인코퍼레이티드 혈관 과투과성과 부종 및 이로부터 발생하는 다른 부작용을 저해하는 방법
BR112015014261A8 (pt) 2012-12-19 2019-10-08 Ampio Pharmaceuticals Inc composto de danazol, seu uso e formulação farmacêutica compreendendo este

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Also Published As

Publication number Publication date
JPS6220998B2 (fr) 1987-05-11
GB2088878B (en) 1983-01-19
SE433221B (sv) 1984-05-14
IE782492L (en) 1979-06-20
DE2855091A1 (de) 1979-06-28
CH637409A5 (fr) 1983-07-29
AU518997B2 (en) 1981-10-29
IE48076B1 (en) 1984-09-19
PH14778A (en) 1981-12-09
JPS6361314B2 (fr) 1988-11-28
IL56076A (en) 1983-06-15
GB2010278B (en) 1982-10-20
IL56076A0 (en) 1979-01-31
NO784281L (no) 1979-06-21
FI66010C (fi) 1984-08-10
AR222645A1 (es) 1981-06-15
NL190848C (nl) 1994-09-16
AU4208978A (en) 1979-06-28
MX5535E (es) 1983-09-27
HK89287A (en) 1987-12-11
DK156727C (da) 1990-03-12
IT7831011A0 (it) 1978-12-19
LU80673A1 (fr) 1979-07-20
JPS62142198A (ja) 1987-06-25
SE7813067L (sv) 1979-06-21
ZA786746B (en) 1979-11-28
FI66010B (fi) 1984-04-30
DE2855091C2 (fr) 1988-12-22
DK156727B (da) 1989-09-25
PH16835A (en) 1984-03-15
GB2088878A (en) 1982-06-16
NO151467C (no) 1985-04-17
PT68926A (en) 1979-01-01
GB2010278A (en) 1979-06-27
FR2412569A1 (fr) 1979-07-20
FR2412569B1 (fr) 1982-05-28
NO151467B (no) 1985-01-02
JPS5488253A (en) 1979-07-13
NZ189035A (en) 1980-08-26
FI783901A (fi) 1979-06-21
ATA888578A (de) 1981-10-15
NL7812309A (nl) 1979-06-22
DK569678A (da) 1979-06-21
NL190848B (nl) 1994-04-18
IT1195258B (it) 1988-10-12
ES476117A1 (es) 1979-11-16
CA1121340A (fr) 1982-04-06
AT367070B (de) 1982-05-25
US4160027A (en) 1979-07-03

Similar Documents

Publication Publication Date Title
BE872489A (fr) Derives heterosidiques de pleuromutiline et leur utilisation therapeutique
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE861224A (fr) Esters steroidiques, leur preparation et leur utilisation
BE872886A (fr) Steroides, leur preparation et leur utilisation therapeutique
BE889401A (fr) 10-alcynyl steroides, leur preparation et leur utilisation
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE840797A (fr) Derives de (1-( , , -triallyakyl)4-phenyl-4-piperidine)methanols, leurpreparation et leur utilisation therapeutique
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE870196A (fr) Colorants, leur preparation et leur utilisation
BE863702A (fr) Tetrazolylcarbamoylquinoleines et leur preparation
LU80719A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE868953A (fr) Peptides, leur preparation et leur utilisation
BE864484A (fr) Benzylpyridimines, leur preparation et leurs utilisations therapeutiques
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE869959A (fr) 2-1-benzisothiazoles, leur preparation et leur utilisation therapeutique
BE876680A (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
BE865834A (fr) Thiobenzylpyrimidines, leur preparation et leurs utilisations therapeutiques
BE855591A (fr) Neoviridogriseines, leur preparation et leur utilisation

Legal Events

Date Code Title Description
CH Change of patent owner
RE20 Patent expired

Owner name: S.A. SANOFI

Effective date: 19981220